1. Home
  2. MBBC vs PLUR Comparison

MBBC vs PLUR Comparison

Compare MBBC & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBBC

Marathon Bancorp Inc.

HOLD

Current Price

$14.00

Market Cap

33.5M

Sector

Finance

ML Signal

HOLD

Logo Pluri Inc.

PLUR

Pluri Inc.

N/A

Current Price

$3.38

Market Cap

33.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MBBC
PLUR
Founded
1902
2001
Country
United States
Israel
Employees
N/A
N/A
Industry
Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.5M
33.9M
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
MBBC
PLUR
Price
$14.00
$3.38
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
1.8K
6.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.78
EPS
N/A
N/A
Revenue
N/A
$1,336,000.00
Revenue This Year
N/A
$97.38
Revenue Next Year
N/A
$293.97
P/E Ratio
$47.11
N/A
Revenue Growth
N/A
309.82
52 Week Low
$9.94
$2.82
52 Week High
$14.64
$7.13

Technical Indicators

Market Signals
Indicator
MBBC
PLUR
Relative Strength Index (RSI) 61.97 44.88
Support Level $10.05 $3.13
Resistance Level N/A $3.42
Average True Range (ATR) 0.25 0.17
MACD 0.02 -0.05
Stochastic Oscillator 66.14 18.95

Price Performance

Historical Comparison
MBBC
PLUR

About MBBC Marathon Bancorp Inc.

Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: